Compare ABCB & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCB | MMED |
|---|---|---|
| Founded | 1971 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.1B |
| IPO Year | 2010 | 2025 |
| Metric | ABCB | MMED |
|---|---|---|
| Price | $81.63 | $18.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $93.00 | $25.47 |
| AVG Volume (30 Days) | 422.5K | ★ 15.1M |
| Earning Date | 10-22-2026 | 11-24-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 15.61 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $5.88 | $10.76 |
| Revenue Next Year | $4.08 | $8.51 |
| P/E Ratio | $35.06 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $69.58 | $10.65 |
| 52 Week High | $93.22 | $24.43 |
| Indicator | ABCB | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 60.49 | 52.52 |
| Support Level | $82.53 | $16.55 |
| Resistance Level | $87.19 | $20.88 |
| Average True Range (ATR) | 1.55 | 0.76 |
| MACD | 0.48 | 0.19 |
| Stochastic Oscillator | 71.69 | 76.35 |
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.